Bruker Corp. (NASDAQ:BRKR) – Research analysts at Leerink Swann issued their FY2016 earnings estimates for shares of Bruker Corp. in a report released on Wednesday. Leerink Swann analyst P. Souda forecasts that the brokerage will post earnings per share of $1.10 for the year. Leerink Swann currently has a “Market Perform” rating and a $21.00 target price on the stock. Leerink Swann also issued estimates for Bruker Corp.’s Q4 2016 earnings at $0.37 EPS and FY2017 earnings at $1.09 EPS.

A number of other analysts have also issued reports on the company. Wells Fargo & Co. lowered Bruker Corp. from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 3rd. Janney Montgomery Scott raised Bruker Corp. from a “neutral” rating to a “buy” rating and set a $28.00 target price on the stock in a research report on Wednesday, August 3rd. BTIG Research reissued a “neutral” rating on shares of Bruker Corp. in a research report on Friday, July 22nd. Zacks Investment Research raised Bruker Corp. from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a research report on Monday, November 7th. Finally, Mizuho cut their target price on Bruker Corp. from $28.00 to $23.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 3rd. Two analysts have rated the stock with a sell rating, ten have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $25.73.

Earnings History and Estimates for Bruker Corp. (NASDAQ:BRKR)

Shares of Bruker Corp. (NASDAQ:BRKR) opened at 22.87 on Monday. The stock has a 50 day moving average price of $21.68 and a 200-day moving average price of $23.61. The firm has a market cap of $3.68 billion, a PE ratio of 25.84 and a beta of 1.04. Bruker Corp. has a 52-week low of $19.58 and a 52-week high of $29.85.

Bruker Corp. (NASDAQ:BRKR) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported $0.32 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.20 by $0.12. The firm earned $393.90 million during the quarter, compared to analysts’ expectations of $394.14 million. Bruker Corp. had a return on equity of 26.05% and a net margin of 9.02%. The business’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter last year, the firm earned $0.19 EPS.

A number of institutional investors have recently added to or reduced their stakes in BRKR. GSA Capital Partners LLP increased its position in Bruker Corp. by 86.0% in the second quarter. GSA Capital Partners LLP now owns 150,990 shares of the company’s stock valued at $3,434,000 after buying an additional 69,804 shares in the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Bruker Corp. during the first quarter valued at $1,842,000. Seven Eight Capital LLC acquired a new stake in shares of Bruker Corp. during the first quarter valued at $319,000. Babson Capital Management LLC acquired a new stake in shares of Bruker Corp. during the first quarter valued at $1,350,000. Finally, Panagora Asset Management Inc. increased its stake in shares of Bruker Corp. by 4,194.0% in the first quarter. Panagora Asset Management Inc. now owns 202,763 shares of the company’s stock valued at $5,677,000 after buying an additional 198,041 shares during the period. Institutional investors own 68.59% of the company’s stock.

Bruker Corp. Company Profile

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

5 Day Chart for NASDAQ:BRKR

Receive News & Stock Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related stocks with our FREE daily email newsletter.